A recent study identified the AML cells with isocitrate dehydrogenase gene (IDH)-R132H mutation as good responders to 1,25D due to the higher levels of VDR protein than in the cells with wt-IDH [21]. Here, IDH2 is linked to acute myeloid leukemia.